Leap Therapeutics Shares Tumble After Downgrades from Baird, HC Wainwright

MT Newswires Live
01-30

Leap Therapeutics (LPTX) shares were down nearly 13% in recent trading Wednesday after Baird and HC Wainwright downgraded the stock to neutral.

Baird also trimmed its price target to $1.25 from $9. The stock was previously rated outperform at Baird and buy at HC Wainwright.

Almost 3 million shares traded so far, compared with a daily average of about 612,000.

Price: 0.57, Change: -0.08, Percent Change: -12.92

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10